171 related articles for article (PubMed ID: 36254139)
1. Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) and Its Correlation with Immune Infiltration in Pan-Cancer.
Liu AR; Liu YN; Shen SX; Yan LR; Lv Z; Ding HX; Wang A; Yuan Y; Xu Q
Biomed Res Int; 2022; 2022():4009354. PubMed ID: 36254139
[TBL] [Abstract][Full Text] [Related]
2. An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis.
Chen YJ; Hong WF; Liu ML; Guo X; Yu YY; Cui YH; Liu TS; Liang L
Cell Death Dis; 2022 Mar; 13(3):237. PubMed ID: 35288533
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy.
Rochette L; Meloux A; Zeller M; Malka G; Cottin Y; Vergely C
Molecules; 2020 May; 25(10):. PubMed ID: 32455902
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
8. Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer.
Wang J; Akter R; Shahriar MF; Uddin MN
Pathol Oncol Res; 2022; 28():1610350. PubMed ID: 35991839
[No Abstract] [Full Text] [Related]
9. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
[TBL] [Abstract][Full Text] [Related]
10. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
11. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
12. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
[TBL] [Abstract][Full Text] [Related]
13. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
15. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
16. Immune and stromal related genes in colon cancer: Analysis of tumour microenvironment based on the cancer genome atlas (TCGA) and gene expression omnibus (GEO) databases.
Wu Y; Jia H; Zhou H; Liu X; Sun J; Zhou X; Zhao H
Scand J Immunol; 2022 Feb; 95(2):e13119. PubMed ID: 34796980
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analyses of Stromal-Immune Score-Related Competing Endogenous RNA Networks In Colon Adenocarcinoma.
Tong Y; Peng M; Li J; Niu Y
Dis Markers; 2022; 2022():4235305. PubMed ID: 35607443
[TBL] [Abstract][Full Text] [Related]
18. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
